As of 2026-04-03, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.5x - 11.1x | 7.8x |
| Forward P/E multiples | 5.8x - 13.6x | 9.4x |
| Fair Price | (70.92) - (96.81) | (84.45) |
| Upside | -5353.2% - -7271.2% | -6355.8% |
| Date | EV/EBITDA |